Anaptysbio (ANAB) Net Cash Flow (QoQ) (2016 - 2026)
Anaptysbio (ANAB) Net Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Anaptysbio |
1.66 Bn |
1.38 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-92.00% |
| Dec 31, 2025 |
95.87% |
| Sep 30, 2025 |
220.60% |
| Jun 30, 2025 |
-122.31% |
| Mar 31, 2025 |
64.32% |
| Dec 31, 2024 |
-157.20% |
| Sep 30, 2024 |
560.71% |
| Jun 30, 2024 |
2.23% |
| Mar 31, 2024 |
83.35% |
| Dec 31, 2023 |
208.52% |
| Sep 30, 2023 |
84.99% |
| Jun 30, 2023 |
-355.25% |
| Mar 31, 2023 |
82.23% |
| Dec 31, 2022 |
197.01% |
| Sep 30, 2022 |
86.11% |
| Jun 30, 2022 |
71.24% |
| Mar 31, 2022 |
-306.67% |
| Dec 31, 2021 |
3,811.17% |
| Sep 30, 2021 |
-91.53% |
| Jun 30, 2021 |
42.78% |
